Allworth Financial LP

Position in KRYS — Krystal Biotech, Inc.

CIK 1555170 FOLSOM, CA

Position in KRYS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$174,313

+$161,914 QoQ

Shares Held

469

+877.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#314

of 419 holders

Holding Since

Jun 2022

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Allworth Financial LP holds $18,605,553 across 285 Biotechnology names. KRYS ranks #17 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	37,664	$2,947,961
2	VRTX	Vertex Pharmaceuticals Inc / Ma	4,487	$2,228,827
3	MDGL	Madrigal Pharmaceuticals, Inc.	3,562	$1,912,615
4	REGN	Regeneron Pharmaceuticals, Inc.	2,530	$1,577,556
5	INCY	Incyte Corp	5,182	$587,431
6	EXEL	Exelixis, Inc.	10,562	$574,678
7	CRSP	CRISPR Therapeutics AG	10,089	$550,254
8	RVMD	Revolution Medicines, Inc.	2,240	$419,507

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$174,313	469	+877.1%	Shares	Sole	2026-08-11
2026-03-31	$12,399	48	+77.8%	Shares	Sole	2026-05-15
2025-12-31	$6,656	27	+35.0%	Shares	Sole	2026-02-05
2025-09-30	$3,530	20	-54.5%	Shares	Sole	2025-12-02
2025-06-30	$6,048	44	+69.2%	Shares	Sole	2025-08-07
2025-03-31	$4,687	26	+333.3%	Shares	Sole	2025-04-30
2024-12-31	$939	6	-14.3%	Shares	Sole	2025-01-30
2024-09-30	$1,274	7	-22.2%	Shares	Sole	2024-10-23
2024-06-30	$1,652	9	+50.0%	Shares	Sole	2024-07-24
2024-03-31	$1,067	6	+200.0%	Shares	Sole	2024-04-25
2023-12-31	$248	2	0.0%	Shares	Sole	2024-01-24
2023-09-30	$232	2	0.0%	Shares	Sole	2023-10-31
2023-06-30	$234	2	0.0%	Shares	Sole	2023-07-18
2023-03-31	$160	2	0.0%	Shares	Sole	2023-04-18
2022-12-31	$158	2	0.0%	Shares	Sole	2023-01-13
2022-09-30	$139	2	0.0%	Shares	Sole	2022-11-14
2022-06-30	$131	2	—	Shares	Sole	2022-07-13
No filing history on record for this holder in this stock.